Trial intelligence / Profile preview

Retin-A Micro for Acne Recurrence Prevention Post-Isotretinoin

NCT00939133Phase 4Completed

Sponsor
Dermatrials Research
Start
Jul 2009
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in acne vulgaris comparing Tretinoin microsphere 0.04% gel with Vehicle gel (2 arms). Primary endpoint: Recurrence rate of acne post isotretinoin use at 6 months. Started Jul 2009; status: completed.

02

Drugs

tretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00939133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00939133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call